Join to View Full Profile
1630 SE 18th StBldg 600 Ste 602Ocala, FL 34471
Phone+1 352-369-0181
Fax+1 352-369-0246
Dr. Reynolds is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1990 - 1993- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1987 - 1990
- Washington University in St. Louis School of MedicineClass of 1987
Certifications & Licensure
FL State Medical License 1993 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Sunitinib Non Small Cell Lung Cancer Patients Over 70 Start of enrollment: 2009 Feb 01
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
- Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 118 citationsContinuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.David M. Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen A. Hussein
Journal of Clinical Oncology. 2020-09-10 - 30 citationsA Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple MyelomaJacob P. Laubach, Chia Jen Liu, Noopur Raje, Andrew Yee, Philippe Armand
Clinical Cancer Research. 2019-01-15 - 12 citationsMolecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.Fred R. Hirsch, Keith M. Kerr, Paul A. Bunn, Edward S. Kim, Coleman K. Obasaju
Clinical Lung Cancer. 2018-07-01
Press Mentions
American Oncology Network, LLC Expands Board with Physician AppointmentsSeptember 13th, 2019
Physicians with Florida Cancer Affiliates Honored for Contributions to Clinical ResearchMarch 8th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
